Editorials
1 Results
- Editorial
Snake Antivenom Product Guidelines in India: “The Devil is in the Details”
Wilderness & Environmental MedicineVol. 18Issue 3p163–168Published in issue: September, 2007- Ian D. Simpson
- Robert L. Norris
Cited in Scopus: 23Venomous snakebite continues to exact a tremendous toll in human suffering and mortality in India. Contributing to this problem is the fact that all of the current Indian snake antivenom manufacturers include a great deal of misinformation in the package inserts and guidelines that accompany their products. Examples include erroneous recommendations regarding first aid, misleading information regarding the signs and symptoms to be anticipated after Indian snakebite, and misleading and ambiguous recommendations as to initial dosing and repeat dosing of antivenom.
